Preliminary results of a phase I study of sunitinib plus paclitaxel for first-line treatment of advanced breast cancer

被引：0
|
作者：
Kozloff, Mark [1 ]
Chuang, Ellen [2 ]
Roy, Jessica [3 ]
Starr, Alexander [1 ]
Gowland, Patricia A. [1 ]
Tarpey, Matthew J. [2 ]
Collier, Mary [4 ]
Verkh, Lev [4 ]
Kern, Kenneth [4 ]
Miller, Kathy [3 ]
机构：
[1] Ingalls Mem Hosp, Harvey, IL USA
[2] Cornell Univ, Weill Med Coll, New York, NY USA
[3] Indiana Univ Canc Ctr, Indianapolis, IN USA
[4] Pfizer Global Res & Dev, La Jolla, CA USA
来源：
MOLECULAR CANCER THERAPEUTICS | 2007年 / 6卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3591S / 3591S
页数：1
相关论文
共 50 条
  • [21] Phase III trial evaluating paclitaxel plus carboplatin versus paclitaxel plus epirubicin as first-line treatment for metastatic breast cancer
    Tong, Zhongsheng
    Li, Shufen
    Shi, Yehui
    Wang, Xu
    Hao, Chunfang
    He, Lihong
    Dong, Guolei
    Wang, Xiaorui
    Jia, Yongsheng
    Zhang, Li
    CANCER RESEARCH, 2015, 75
  • [22] Paclitaxel (Taxol(R)) plus carboplatin as first-line treatment for advanced ovarian cancer
    Ozols, RF
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1996, 6 : 9 - 12
  • [23] Paclitaxel plus carboplatin versus paclitaxel plus epirubicin as first-line treatment for metastatic breast cancer: Efficacy and safety results of a randomized, phase III trial.
    Tong, Zhongsheng
    Li, Shufen
    Shi, Yehui
    Wang, Xu
    Wang, Chen
    Hao, Chunfang
    Wang, Xiaorui
    Meng, Wenjin
    Zhang, Li
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [24] Paclitaxel and carboplatin as first-line chemotherapy for advanced breast cancer
    Fountzilas, G
    Athanassiades, A
    Papadimitriou, V
    Dimopoulos, MA
    Bafaloukos, D
    Aravantinos, G
    Nicolaides, C
    Kalofonos, HR
    Papakostas, P
    Xiros, N
    Razi, E
    ONCOLOGY-NEW YORK, 1998, 12 (01): : 45 - 48
  • [25] Phase III, Double-Blind, Randomized Study Comparing Lapatinib Plus Paclitaxel With Placebo Plus Paclitaxel As First-Line Treatment for Metastatic Breast Cancer
    Di Leo, Angelo
    Gomez, Henry L.
    Aziz, Zeba
    Zvirbule, Zanete
    Bines, Jose
    Arbushites, Michael C.
    Guerrera, Stephanie F.
    Koehler, Maria
    Oliva, Cristina
    Stein, Steven H.
    Williams, Lisa S.
    Dering, Judy
    Finn, Richard S.
    Press, Michael F.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (34) : 5544 - 5552
  • [26] CETUXIMAB PLUS DOCETAXEL/CISPLATIN (DC) AS FIRST-LINE TREATMENT FOR LOCALLY ADVANCED OR METASTATIC GASTRIC CANCER: PRELIMINARY RESULTS OF A PHASE II STUDY
    Fahlke, J.
    Ridwelski, K.
    Florschuetz, A.
    Kettner, E.
    Leithaeuser, M.
    Kroehning, H.
    Stuebs, P.
    Zierau, K.
    Lippert, H.
    ANNALS OF ONCOLOGY, 2009, 20 : 47 - 47
  • [27] BIWEEKLY PACLITAXEL AND CISPLATIN - A PHASE-I/II STUDY IN THE FIRST-LINE TREATMENT OF METASTATIC BREAST-CANCER
    OREILLY, SE
    GELMON, KA
    SEMINARS IN ONCOLOGY, 1995, 22 (03) : 109 - 111
  • [28] A phase I-II study of bi-weekly paclitaxel as first-line treatment in metastatic breast cancer
    Gelmon, KA
    Tolcher, A
    O'Reilly, S
    Campbell, C
    Bryce, C
    Shenkier, T
    Ragaz, J
    Ayers, D
    Nakashima, L
    Rielly, S
    Dulude, H
    ANNALS OF ONCOLOGY, 1998, 9 (11) : 1247 - 1249
  • [29] A phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer
    Steven J. Cohen
    Mark M. Zalupski
    Manuel R. Modiano
    Paul Conkling
    Yehuda Z. Patt
    Peg Davis
    Robert T. Dorr
    Michelle L. Boytim
    Evan M. Hersh
    Cancer Chemotherapy and Pharmacology, 2010, 66 : 287 - 294
  • [30] A phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer
    Cohen, Steven J.
    Zalupski, Mark M.
    Modiano, Manuel R.
    Conkling, Paul
    Patt, Yehuda Z.
    Davis, Peg
    Dorr, Robert T.
    Boytim, Michelle L.
    Hersh, Evan M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (02) : 287 - 294
12345